Carcinoids are rare neuroendocrine tumors, mainly located in the bowel, stomach and lung. Familial risks in carcinoid tumours are not well known apart from multiple endocrine neoplasia 1 (MEN1). We used the nation-wide Swedish Family-Cancer Database on 10.1 million individuals for assessment. Carcin
Familial and second esophageal cancers: A nation-wide epidemiologic study from Sweden
✍ Scribed by Kari Hemminki; Yongwen Jiang
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 63 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A few case‐control studies have been published on familial risks in esophageal cancer. Reliable data on familial risks are needed for prevention and clinical decisions. We used the nation‐wide Swedish Family‐Cancer Database on 10.1 million individuals and close to 6000 esophageal cancers to calculate standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for esophageal cancer in 0–66‐year‐old offspring by cancers in family members. Additionally, SIRs for second esophageal cancers were analyzed. The SIR for esophageal cancer was 3.91 (95% CI 1.55–7.35) when a parent presented with esophageal cancer and 4.91 (95% CI 1.77–9.62) when a parent presented with squamous cell carcinoma. The sibling risk for esophageal cancer was increased but was based on 1 pair only. The population‐attributable proportion of familial esophageal cancer was 0.70%. Risks for second esophageal cancers were increased after upper aerodigestive tract, esophageal, stomach, larynx, and lung cancers. The data on second cancers suggest that environmental factors are important for esophageal cancer and probably contribute to the familial clustering. However, the high familial risk of 3.91 is unlikely without the involvement of heritable factors. The population‐attributable proportion of familial esophageal cancer is small. © 2001 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Familial risk of pancreatic cancer has been mainly assessed through case‐control studies based on reported but not medically verified cancers in family members. We used the nationwide Swedish Family‐Cancer Database on 10.2 million individuals and 21,000 pancreatic cancers to calculate s
There is a familial aggregation of prostate cancer, and 5 to 10% of all prostate cancers are estimated to be inherited in an autosomal-dominant mode. A population-based cohort study was performed in order to study familial prostate cancer and associated malignancies. A nation-wide register cohort st
## Abstract ## BACKGROUND Familial risks in patients with breast carcinoma have not been assessed by morphologic types of medically verified cancers. Reliable data on familial risks would help to establish prevention programs and guide clinical decisions. ## METHODS We used the nationwide Swedis
## Abstract Population attributable factions (PAFs) show the proportion of the disease that could be prevented if the cause could be removed. The PAF for familial breast cancer has not been precisely determined. We used the nationwide Swedish Family‐Cancer Database on 10.2 million individuals and 1